[CYTOSTATIC THERAPY].
D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002066:Busulfan; D002699:Chlorambucil; D003078:Colchicine; D003520:Cyclophosphamide; D005260:Female; D005493:Folic Acid Antagonists; D040181:Genetic Diseases, X-Linked; D006801:Humans; D007414:Intestinal Neoplasms; D007938:Leukemia; D007943:Leukemia, Hairy Cell; D008175:Lung Neoplasms; D008206:Lymphatic Diseases; D009588:Nitrogen Mustard Compounds; D010051:Ovarian Neoplasms; D011687:Purines; D011743:Pyrimidines; D016511:Severe Combined Immunodeficiency; D013274:Stomach Neoplasms; D013852:Thiotepa; D014116:Toxicology; D014520:Urethane; D014565:Urogenital Neoplasms; D014747:Vinblastine
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D009588:Nitrogen Mustard Compounds; D011687:Purines; D011743:Pyrimidines; D002699:Chlorambucil; D014520:Urethane; D014747:Vinblastine; D003520:Cyclophosphamide; D013852:Thiotepa; D002066:Busulfan; D003078:Colchicine
ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BUSULFAN; CHLORAMBUCIL; COLCHICINE; CYCLOPHOSPHAMIDE; FOLIC ACID ANTAGONISTS; INTESTINAL NEOPLASMS; LEUKEMIA; LUNG NEOPLASMS; NITROGEN MUSTARD COMPOUNDS; OVARIAN NEOPLASMS; PURINES; PYRIMIDINES; RETICULOENDOTHELIOSIS; STOMACH NEOPLASMS; THIO-TEPA; TOXICOLOGIC REPORT; URETHANE; UROGENITAL NEOPLASMS; VINBLASTINE
CYTOSTATISCHE THERAPIE.